SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056927
Filing Date
2020-12-14
Accepted
2020-12-14 06:03:37
Documents
13
Period of Report
2020-12-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-8k_20201214.htm   iXBRL 8-K 43085
2 EX-99.1 d55839dex991.htm EX-99.1 10109
  Complete submission text file 0001564590-20-056927.txt   191782

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20201214.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20201214_lab.xml EX-101.LAB 20227
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20201214_pre.xml EX-101.PRE 12078
6 EXTRACTED XBRL INSTANCE DOCUMENT sybx-8k_20201214_htm.xml XML 3642
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 201384984
SIC: 2834 Pharmaceutical Preparations